Genetic markers in methotrexate treatments. [electronic resource]
Producer: 20190314Description: 689-703 p. digitalISSN:- 1473-1150
- Antimetabolites, Antineoplastic -- administration & dosage
- Clinical Decision-Making
- Humans
- Immunosuppressive Agents -- administration & dosage
- Methotrexate -- administration & dosage
- Methylenetetrahydrofolate Reductase (NADPH2) -- genetics
- Patient Selection
- Pharmacogenetics -- methods
- Pharmacogenomic Testing
- Pharmacogenomic Variants
- Polymorphism, Genetic
- Precision Medicine -- methods
- Predictive Value of Tests
- Reduced Folate Carrier Protein -- genetics
- Risk Assessment
- Thymidylate Synthase -- genetics
No physical items for this record
Publication Type: Journal Article; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.